The term “cooperation agreement” has also been referred to as a consultation agreement, a collaborative pharmacy practice agreement, a physician-pharmacist agreement, a permanent order or a permanent protocol, and a physician delegation.  A Collaborative Practice Agreement is a legal document in the United States that establishes a formal relationship between pharmacists (often clinical pharmacy specialists) and cooperating physicians, in order to create a legal and ethical basis for pharmacists involved in collaborative therapy management.   Pharmacists who participate in CPAs may participate in clinical services outside the traditional practice of pharmacists. In particular, pharmacists are not required to participate in CPAs to provide many pharmacy practice services that are already within their traditional practice area, such as .B. the implementation of drug therapy management, the provision of disease prevention services (for example. Vaccination), participation in public health screenings (e.g. B screening patients for depressive disorders such as. B severe depressive disorders, through the administration of PHQ-2), the provision of specific information related to the disease (for example. B as a certified patient).
, and advise patients on information about their medications.  Advanced pharmacy services under a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them. This may include prescribing drugs to select and initiate drugs to treat a patient`s diagnosed illnesses (as described in the CPA), stopping the use of prescription or over-the-counter drugs, and modifying a patient`s drug treatment (for example. B change in strength, frequency, frequency of administration or duration of therapy), evaluation of a patient`s response to drug treatment (including drug treatment). , such as.B. a basic metabolic panel) and the continuation of drug therapy (with a new prescription).  To participate in CPAs, pharmacists must be able to assess the health status of their patients, implement a pharmaceutical care plan, communicate with stakeholders and monitor patient progress.